Evidence map›Paper›PMID 38533179›Full record

ReviewToxicology research2024

New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption.

Fiona Sewell, Camilla Alexander-White, Susy Brescia, Richard A Currie, Ruth Roberts, Clive Roper, Catherine Vickers, Carl Westmoreland, Ian Kimber

Abstract readReview
In one paragraph

Review in Toxicology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Hepatic cellular stress response pathways exhibit species differences in basal and inducible activity.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fiona SewellUK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, United Kingdom.ORCID https://orcid.org/0000-0001-5589-9453
Camilla Alexander-WhiteMKTox & Co Ltd, 80 Compair Crescent, Ipswich, IP2 0EH, United Kingdom.
Susy BresciaUK Chemicals Regulation Division, Health and Safety Executive, Redgrave Court, Bootle, Merseyside, L20 7HS, United Kingdom.ORCID https://orcid.org/0000-0001-7975-2683
Richard A CurrieJealotts Hill International Research Centre, Syngenta, Bracknell, RG42 6EX, United Kingdom.ORCID https://orcid.org/0000-0002-6528-3326
Ruth RobertsUniversity of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom.ORCID https://orcid.org/0000-0002-7763-7558
Clive RoperRoper Toxicology Consulting Limited, 6 St Colme Street, Edinburgh, EH3 6AD, United Kingdom.ORCID https://orcid.org/0000-0002-0777-7969
Catherine VickersUK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London, NW1 2BE, United Kingdom.
Carl WestmorelandSafety & Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook, Bedfordshire, MK44 1LQ, United Kingdom.
Ian KimberFaculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New approach methodologies (NAMs) can deliver improved chemical safety assessment through the provision of more protective and/or relevant models that have a reduced reliance on animals. Despite the widely acknowledged benefits offered by NAMs, there continue to be barriers that prevent or limit their application for decision-making in chemical safety assessment. These include barriers related to real and perceived scientific, technical, legislative and economic issues, as well as cultural and societal obstacles that may relate to inertia, familiarity, and comfort with established methods, and

Indexed as

3Rschemical safety assessmentexposure sciencenew approach methodologies (NAMs)risk assessment

Identifiers

PMID38533179
PMCPMC10964841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.